A new study published on March 29 has shown that frequent infusions of infliximab (Remicade) have been shown to make first vaccine doses in both Pfizer and AstraZeneca less effective.
The researchers came to the conclusion that patients who were receiving regular infliximab injections as an antibody treatment for several chronic inflammatory illnesses did not produce enough antibodies to offer protection against COVID-19, after the first vaccine dose.
Remicade is usually used for treating several autoimmune disorders, such as ankylosing spondylitis, psoriatic arthritis, Crohn’s disease, rheumatoid arthritis, ulcerative colitis, and plaque psoriasis.
We all like to have our secrets and keep them private. We don't share them…
I think humanity is the most wonderful thing that can exist. Just imagine that we…
I'm sure that everyone is looking for ways to make their life less complicated, happier,…
We know that the dinosaurs disappeared approximately 65 million years ago, but what we don't…
I am sure that sometimes you wish that you could teleport anywhere and see everything…
Our lifespan has significantly increased over the last century and a half. Back then, it…